Skip to main content
    N

    Nomura Holdings Inc ADR (NMR)

    Official site

    FINANCIAL SERVICES • CAPITAL MARKETS • NYSE

    $9.50
    -0.20 (-2.06%)

    Market Cap: $28.35B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Nomura Holdings Inc ADR (NMR) P/E Ratio & Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Nomura Holdings Inc ADR (NMR) trades at 10.8x trailing earnings and 1.0x sales. Its P/S of 1.0x is above its 5-year median of 0.8x. Its forward P/E is 15.4x. The median P/E across 10 similar companies is 17.8x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 29.9% lower over the next year.

    MultipleValue
    P/E (trailing)10.8x
    Forward P/E15.4x
    Price to sales1.0x
    Price to book1.2x
    EV/EBITDA25.9x
    PEG0.8
    FCF yield-54.5%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 11.1% above 0.9x and its P/B is 71.4% above 0.7x.

    MultipleCurrent5-year median10-year median
    P/S1.0x0.8x0.9x
    P/B1.2x0.8x0.7x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/S ranged from 0.6x in 2024 to 1.5x in 2016.

    Year endPriceP/SP/B
    2025$8.390.9x1.1x
    2024$5.790.6x0.8x
    2023$4.510.6x0.6x
    2022$3.750.8x0.5x
    2021$4.331.2x0.6x
    2020$5.331.1x0.6x
    2019$5.161.0x0.7x
    2018$3.720.8x0.5x
    2017$5.821.3x0.8x
    2016$5.901.5x0.9x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    P/E history is shown only for companies that report in US dollars.

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NMR

    What is NMR's forward P/E ratio?

    Nomura Holdings Inc ADR has a forward P/E ratio of 15.4x.

    Is NMR stock overvalued?

    GNG's valuation label for NMR is Overvalued. Its P/E of 10.8x compares with a median of 17.8x across 10 similar companies.

    What is NMR's price to sales ratio?

    Nomura Holdings Inc ADR has a price to sales ratio of 1.0x.

    What is NMR's PEG ratio?

    Nomura Holdings Inc ADR has a PEG ratio of 0.8.